Stress Ventricular Function in Evaluating Patients With Pulmonary Hypertension

Using the Stress Ventricular Function Assessment to Evaluate the Long-term Prognosis and Treatment Outcome in Patients With Pulmonary Hypertension

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02647034

Enrollment

300

Registered

2016-01-06

Start date

2009-07-31

Completion date

2018-12-31

Last updated

2016-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspnea

Brief summary

This study investigated clinical parameters, laboratory data, imaging studies to evaluate patients with suspected pulmonary hypertension.

Detailed description

Left and right ventricular ejection fraction (LV/RV EF) at rest and immediately after exercise treadmill test (ETT) were measured by nuclear medicine study in consecutively symptomatic patients with suspected pulmonary hypertension, along with other clinical variables were correlated with right heart catheterization parameters.

Interventions

OTHERno intervention

no intervention

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients suspicious for pulmonary hypertension.

Exclusion criteria

* pregnant, lactating, CAD history

Design outcomes

Primary

Measure	Time frame
All-cause mortality	an average of 1 year

Countries

Taiwan

Contacts

Primary ContactMei-Fang Cheng, M.D.

meifang@ntuh.gov.tw886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026